Core Viewpoint - GuangYuYuan Chinese Herbal Medicine Co., Ltd. is preparing for its 2024 annual shareholders' meeting, focusing on maintaining shareholder rights and ensuring efficient proceedings [1][2][3]. Meeting Arrangements - The annual shareholders' meeting is scheduled for June 24, 2025, at 14:00 in Taiyuan, Shanxi [3]. - Shareholders must arrive 30 minutes early for registration and are limited to three minutes for speaking [2][3]. - Voting will occur both on-site and through internet platforms during specified time slots [3]. Agenda Items - The meeting will cover several key reports, including the 2024 annual work report from the board of directors, the supervisory board's report, financial statements, profit distribution plans, and independent directors' reports [3][4][5]. Board of Directors' Report - The board held six meetings during the reporting period, addressing various operational and financial matters, including accounting errors and annual reports [6][7]. - The company reported total assets of 2.276 billion and net assets of 1.570 billion as of December 31, 2024, with a revenue of 1.221 billion, a decrease of 4.87% year-on-year [13]. Operational Focus - The company emphasizes growth and operational efficiency, focusing on four core products and expanding its market presence through partnerships and new store openings [13][14]. - A cultural heritage strategy is in place to enhance brand influence, including collaborations with educational institutions and media [14][15]. Quality Assurance - The company is committed to high-quality production standards, implementing a comprehensive quality management system and collaborating with research institutions for innovation [15][16][20]. Governance and Compliance - The company is enhancing its governance structure, focusing on compliance and risk management, and has revised various internal regulations to ensure transparency and accountability [17][22][27]. Future Strategy - The company aims to strengthen its market position by leveraging its historical and cultural assets, enhancing brand visibility, and driving innovation through technology [19][21][22].

广誉远中药 股份有限公 司 GuangYuYuan Chinese Herbal Medicine Co., Ltd. 2024 年年度股东大会 会议资料 二〇二五年六月二十四日 中国·山西·太原 | | | | 一、公司 | 2024 | 年年度股东大会会议须知 3 | | --- | --- | --- | | 二、公司 | 2024 | 年年度股东大会会议议程 4 | | 三、公司董事会 | | 2024 年度工作报告 6 | | 四、公司监事会 | | 年度工作报告 2024 15 | | 五、公司 | 2024 | 年度财务决算报告 18 | | 六、公司 | 2024 | 年度利润分配预案 26 | | 七、公司独立董事 | | 2024 年度述职报告 27 | | 八、公司 | 2024 | 年年度报告及摘要 51 | | 九、公司关于未弥补亏损超过实收股本总额三分之一的议案 52 | | | | 十、公司 | 2024 | 年度计提信用减值损失和资产减值准备的议案 54 | | 十一、关于续聘 | | 2025 年年度财务审计机构暨内部控制审计机构的议案 58 | | 十二、公司关于取消监事会 ...

Core Viewpoint - Guangyuyuan Traditional Chinese Medicine Co., Ltd. plans to cancel its supervisory board and amend its articles of association to enhance corporate governance and comply with the new Company Law [1][2]. Summary by Sections Cancellation of Supervisory Board and Amendments to Articles of Association - The company’s board of directors unanimously approved the proposal to cancel the supervisory board, transferring its powers to the audit committee of the board [1]. - The amendments to the articles of association and related rules include changes to the shareholder meeting rules, board meeting rules, independent director system, and cash dividend management system [1][2]. Details of Amendments - The amendments aim to improve the operational standards of the company and align with the guidelines for listed companies [1]. - Specific changes include the definition of the legal representative, responsibilities of the board, and the rights and obligations of shareholders [2][3][5]. Shareholder Meeting Procedures - The proposal requires approval from the shareholders' meeting, and until then, the current supervisory board will continue its duties [2]. - The revised articles will enhance the clarity of shareholder rights and the procedures for convening meetings [2][10]. Financial and Operational Governance - The amendments also address the management of financial assistance and the conditions under which the company can provide guarantees [5][23]. - The company will ensure that any financial assistance provided does not exceed 10% of the total issued share capital [5][23]. Compliance and Legal Framework - The company emphasizes adherence to legal requirements and the importance of transparency in its operations [1][10]. - The amendments include provisions for the handling of disputes regarding the validity of board and shareholder resolutions [10][11].

广誉远中药股份有限公司担保管理办法 第一章 总 则 第一条 为规范广誉远中药股份有限公司（以下简称"上市公司"）及所属子公 司的担保行为，完善担保业务流程，最大限度规避担保风险，根据《中华人民共和 国公司法》《山西省省属企业担保管理暂行办法》《山西省国有资本运营有限公司 出资企业担保管理办法》《上市公司监管指引第 8 号-上市公司资金往来、对外担保 的监管要求》《上海证券交易所股票上市规则》等法律法规以及公司章程，结合公 司实际，制定本办法。 第二条 担保是指按法律规定或者当事人约定，为确保合同履行，保障债权人利 益实现的法律措施。担保方式包括保证、抵押、质押等方式。 第三条 本办法适用于上市公司、全资子公司、控股公司（全资子公司、控股公 司以下简称"所属公司"），参股公司参照执行。 第四条 上市公司及所属公司仅对开展的融资业务进行担保，且原则上只采用保 证方式。严禁对其他经营类债权债务业务提供担保。 第五条 上市公司对所属公司、各子公司对所属公司的担保均适用本管理办法。 第六条 上市公司提供担保，应根据《中华人民共和国证券法》《上海证券交易 所股票上市规则》以及《公司章程》及其他相关规定，履行对外担保的信息 ...

Core Points - The company has established a system to regulate online voting behavior at shareholder meetings to facilitate the exercise of voting rights and protect investors' legal rights [1] - The online voting system is provided through the Shanghai Stock Exchange, allowing shareholders to vote via both trading system and internet platforms [1][2] - Shareholders registered on the equity registration date have the right to vote online, but can only choose one voting method [1][3] Group 1 - The company may engage the designated information company to provide services related to online voting and can sign service agreements to clarify rights and obligations [2] - Notifications for shareholder meetings must include details about the types of participating shareholders, categorized by A shares, B shares, and preferred shares [2] - In case of changes such as postponements or additional proposals, the meeting convenor must prepare announcements and disclose relevant information two trading days before the meeting [2][3] Group 2 - The company must ensure that the equity registration date and the start date for online voting are at least two trading days apart [3] - The company is required to verify and confirm the accuracy of online voting information on the Shanghai Stock Exchange's information service platform before the voting starts [3][4] - Nominal shareholders can collect voting opinions from actual shareholders through the internet voting platform during specified hours [3][4] Group 3 - Shareholders participating in online voting must follow the procedures outlined in the meeting notice [4] - All proposals must be voted on by attending shareholders, who must express their agreement, opposition, or abstention [4][5] - In cumulative voting for directors, shareholders can allocate their votes among candidates, but exceeding the allowed votes will render those votes invalid [4][5] Group 4 - Shareholders voting on only part of the proposals will still be considered present at the meeting, and their voting rights will be included in the total count [5] - After voting concludes, the company will obtain the results from the information company, and shareholders can check their voting results on the company's website [5] - This system will take effect upon approval by the company's shareholder meeting and will be subject to relevant laws and regulations [5]

独立董事制度 第一条 为规范广誉远中药股份有限公司（以下简称公司）独立董事行为， 充分发挥独立董事在公司治理中的作用，促进提高公司质量，依据《中华人民共 和国公司法》《中华人民共和国证券法》《上市公司独立董事管理办法》（以下 简称管理办法）、《广誉远中药股份有限公司章程》及其他现行有关法律、法规 制定本制度。 第二条 公司独立董事除遵守《中华人民共和国公司法》《中华人民共和国 证券法》《上市公司独立董事管理办法》及其他现行有关法律、法规和《广誉远 中药股份有限公司章程》外亦应遵守本制度的规定。 第三条 董事会设独立董事。独立董事是指不在公司担任除董事外的其他职 务，并与公司及公司主要股东、实际控制人不存在直接或者间接利害关系，或者 其他可能影响其进行独立客观判断的关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或 者个人的影响。 第四条 公司独立董事占董事会成员的比例不得低于三分之一，且至少包括 一名会计专业人士。独立董事应当忠实履行职务，维护公司利益，保护中小股东 的合法权益不受损害。 公司董事会设置审计委员会。其成员为不在公司担任高级管理人员的董事， 其中独立董事过半数，并由 ...

Core Points - GuangYuYuan Chinese Herbal Medicine Co., Ltd. is a publicly listed company established in accordance with the Company Law of the People's Republic of China, with a registered capital of RMB 489,491,141 [2][3] - The company aims to innovate and inherit traditional Chinese medicine culture, contributing to the health of the Chinese people [4] - The company has a comprehensive business scope that includes the production, sales, and research of various traditional and Western medicine forms [4] Company Structure - The company is governed by a board of directors, with the chairman serving as the legal representative [3] - The company has established a party committee and a disciplinary committee to ensure adherence to the leadership of the Communist Party of China [1] - The company has a total of 489,491,141 shares issued, all of which are ordinary shares [5] Share Issuance and Management - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shares of the same category [4][5] - The company can increase its capital through various methods, including issuing shares to unspecified objects or existing shareholders [6][7] - The company is prohibited from acquiring its own shares, except under specific circumstances approved by the shareholders' meeting [6][7] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and the ability to supervise the company's operations [11] - Shareholders are required to comply with laws and the company's articles of association, and they cannot withdraw their capital except as legally permitted [16][40] - The company must maintain transparency and disclose information regarding significant events and shareholder rights [13][17] Governance and Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [48][49] - Shareholder proposals must be submitted in advance, and the company is required to notify shareholders of meeting details [58][59] - Voting at shareholder meetings can be conducted in person or by proxy, with specific rules governing the validity of votes [66][67]

证券代码：600771 证券简称：广誉远 编号：临 2025-009 广誉远中药股份有限公司 第八届董事会第十五次会议决议公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 广誉远中药股份有限公司（以下简称"公司"）第八届董事会第十五次会议于 2025 年 5 月 23 日以电话、邮件及其他网络通讯方式向全体董事发出通知，于 2025 年 6 月 3 日以通讯方式召开。会议应出席董事 6 名，实际出席董事 6 名，符合《公司法》及《公 司章程》的有关规定。会议由董事长李晓军主持，经认真审议，通过了以下议案： 表决情况：同意 6 票，反对 0 票，弃权 0 票。 具体内容详见公司同日在上海证券交易所网站披露的临 2025—010 号公告。 一、审议通过《关于取消监事会暨修订 <公司章程> 的议案》 为贯彻落实新《公司法》，进一步提高公司规范化运作水平，根据《上市公司章程 指引》的有关规定，结合公司实际情况，拟取消公司监事会，监事会的职权由董事会审 计委员会行使，并对《公司章程》中相关条款进行修订。 本次取消监事会暨修 ...

证券代码：600771 证券简称：广誉远 公告编号：2025-011 广誉远中药股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 股东大会召开日期：2025年6月24日 ? 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 （五）网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 24 日 至2025 年 6 月 24 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (一) 股东大会类型和届次 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地 ...

（二）关联方回避原则。 关联交易内部决策规则 第一章 总则 第一条 广誉远中药股份有限公司（以下简称"公司"）为规范关联交易行为， 提高公司规范运作水平，保护公司和全体股东的合法权益，依据《上海证券交易 所股票上市规则》《上海证券交易所上市公司自律监管指引第 5 号——交易与关 联交易》《上市公司信息披露管理办法》和其他有关法律法规的规定，制定本规 则。 第二条 公司在确认和处理有关关联人之间关联关系与关联交易时，须遵循 并贯彻以下原则： （一）诚实信用原则。 予以回避。 （三）有利于公司原则。 公司董事会应当根据客观标准判断该关联交易是否对公司有利。必要时应当 聘请专业评估师或独立财务顾问。 第三条 公司交易与关联交易行为应当定价公允、审议程序合规、信息披露 规范。公司积极通过资产重组、整体上市等方式减少关联交易。 第四条 公司董事会审计委员会履行公司关联交易控制和日常管理的职责。 第二章 关联人和关联交易 第五条 公司的关联人包括： （一）关联法人（或者其他组织）和关联自然人。 （二）具有以下情形之一的法人（或者其他组织），为公司的关联法人（或者 其他组织）： 公司及控制的其他主体以外的法人（或者其他组织 ...